NEW YORK, April 14 (GenomeWeb News) - Orchid Biosciences is seeking stockholder approval to change its name to Orchid Cellmark to reflect the company's positioning as a provider of DNA identity testing services, the firm said yesterday.

Shareholders will consider the name change at the Princeton, NJ-based company's annual stockholders meeting on June 8.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.